Table 2.
Questions in the gap analysis about ASP and ARP.
| Services | Is the Service Currently Performed? Answer Yes/No |
Is the Service Preferred to Develop or Improve in the Future? Answer Yes/No |
|---|---|---|
| Part 1. Services in the ASP | ||
| a. Prospective audit with direct intervention and feedback | □ Yes □ No | □ Yes □ No |
| b. Formulary restriction and preauthorization requirements | □ Yes □ No | □ Yes □ No |
| c. Education | □ Yes □ No | □ Yes □ No |
| d. Evidence-based guidelines and clinical pathways | □ Yes □ No | □ Yes □ No |
| e. Antimicrobial cycling | □ Yes □ No | □ Yes □ No |
| f. Antimicrobial order forms | □ Yes □ No | □ Yes □ No |
| g. Combination therapy | □ Yes □ No | □ Yes □ No |
| h. Streamlining or de-escalation of therapy | □ Yes □ No | □ Yes □ No |
| i. Dose optimization | □ Yes □ No | □ Yes □ No |
| j. Parenteral-to-oral conversion | □ Yes □ No | □ Yes □ No |
| Part 2. ARPs that suggest pharmacist’s intervention | ||
| a. Medications with no medical indication | □ Yes □ No | □ Yes □ No |
| b. Medical conditions for which there is no medication prescribed | □ Yes □ No | □ Yes □ No |
| c. Medications prescribed inappropriately for a particular medical condition | □ Yes □ No | □ Yes □ No |
| d. Inappropriate medication dose, dosage form, schedule, route of administration, or method of administration | □ Yes □ No | □ Yes □ No |
| e. Therapeutic duplication | □ Yes □ No | □ Yes □ No |
| f. Prescribing of medications to which the patient is allergic | □ Yes □ No | □ Yes □ No |
| g. Actual and potential adverse drug events | □ Yes □ No | □ Yes □ No |
| h. Actual and potential clinically significant drug–drug, drug–disease, drug–nutrient, and drug–laboratory test interaction | □ Yes □ No | □ Yes □ No |
| i. Failure to receive the full benefit of prescribed medication therapy | □ Yes □ No | □ Yes □ No |
| j. Problems arising from the financial impact of medication therapy on the patient | □ Yes □ No | □ Yes □ No |
| k. Failure of the patient to adhere to the medication regimen | □ Yes □ No | □ Yes □ No |
IPC/ASP, infection prevention, and control programs/antimicrobial stewardship programs; ARP, antimicrobial-related problems.